MeSH tree: D03.383.129.578.075
Clarifying the cause of a skin disease had led to the discovery of a new disease-causing gene, a new category of diseases, and new perspectives for both counseling and therapy. The discovery is the first time that epigenetic ...
Apr 22, 2024
0
43
A study appearing in MedComm has been led by Dr. Jizong Zhao, Dr. Dong Zhang, and Dr. Peicong Ge (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University and Department of Neurosurgery, Beijing Hospital). ...
Apr 18, 2024
0
56
Plaque afflicts more than just teeth. A cholesterol-infused version of the stuff can also coat the inner lining of arteries, sometimes hardening and narrowing those canals to the point that oxygen-ferrying blood slows and ...
Oct 31, 2023
0
54
Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is associated with lower ...
Oct 18, 2023
0
180
For older versus younger adults, low- to moderate-intensity statins are associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C), according to a study published online Aug. 1 in the Annals of Internal ...
Aug 1, 2023
0
60
We've all recently gotten a crash-course in drug repurposing, thanks to near-daily news reports about efforts to identify existing medicines that could help treat COVID-19 in the early phase of the pandemic. A team of scientists ...
May 9, 2023
0
68
Many adults take prescription drugs, and usage rates are continually increasing. With approximately 1.3 million emergency department visits in the U.S. caused by adverse drug events each year, patient education is becoming ...
Apr 24, 2023
0
27
Among people receiving chemotherapy regimens containing anthracyclines for lymphoma, those who took the cholesterol-lowering drug atorvastatin for one year were significantly less likely to show evidence of heart dysfunction ...
Mar 6, 2023
0
35
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a U.K.-wide trial, led by Addenbrooke's Hospital and the ...
Nov 28, 2022
0
77
A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have ...
Aug 26, 2022
0
133
